RARRES2P7

Across TCGA pan-cancer cohorts, RARRES2P7 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RARRES2P7 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RARRES2P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RARRES2P7 expression acts as an unfavorable survival marker, although some lineages such as OV and KIRC show a favorable association.

STAD, KICH, and UCEC are the cancer types where RARRES2P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.136	0.678	<.001	75	view →
KICH	DFS	Tertile	All	0.369	0.922	<.001	75	view →
UCEC	DFS	Tertile	All	0.275	0.674	.003	54	view →
COAD	DFS	Tertile	IV	0.159	0.503	.006	51	view →
SKCM	DFS	Tertile	III,IV	0.016	0.648	<.001	39	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
LUAD	OS	Tertile	II,III,IV	0.245	0.565	.005	36	view →
LAML	DFS	Tertile	All	0.250	0.579	.024	18	view →
LGG	DFS	Tertile	All	0.391	0.759	.002	18	view →
LIHC	OS	Tertile	All	0.584	0.711	.018	12	view →
ESCA	DFS	Tertile	All	0.238	0.776	.014	9	view →
HNSC	OS	Tertile	III,IV	0.307	0.662	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RARRES2P7–STAD (OS)

Open the STAD breakdown →